PWAM
AMED

Park West Asset Management’s Amedisys AMED Stock Holding History

Park West Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-213,010
Closed -$19.6M – 44
2024
Q2 		$19.6M Sell
213,010
-319,257
-60% -$29.6M 1.43% 28
2024
Q1 		$49.1M Sell
532,267
-279,802
-34% -$26.2M 3.49% 12
2023
Q4 		$77.2M Buy
812,069
+60,350
+8% +$5.64M 7.56% 3
2023
Q3 		$70.2M Buy
751,719
+657,615
+699% +$60.8M 6.45% 4
2023
Q2 		$8.6M Buy
+94,104
New +$7.72M 0.75% 31

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Park West Asset Management's AMED Position: Q3 2024 in Review

Park West Asset Management sold out of Amedisys (AMED) in Q3 2024, closing a stake of 213,010 shares — an estimated $19.6M sold.

Park West Asset Management first reported a position in AMED in Q2 2023 and held it in 5 quarters. The position peaked at $77.2M in Q4 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Park West Asset Management reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Park West Asset Management sold 213,010 Amedisys shares in Q3 2024, an estimated $19.6M.
  • Park West Asset Management first reported a position in Amedisys in Q2 2023 and held it in 5 quarters.
  • Park West Asset Management's Amedisys position peaked at $77.2M in Q4 2023.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Park West Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.